American Well Corporation Class A (AMWL)

American Well Corp.'s stock price has declined by 14.29% in the past six months. As of March 23, 2026, the share price was $5.79, a 28.96% decrease from March 24, 2025. The company reported Q4 2025 revenue of $55.3 million, a 22.1% year-over-year decline, but the stock rose 2.55% due to investor confidence in technology and AI integration efforts. Subscription revenue increased to 53% of total revenue in Q4 2025, up from 45% in 2024, and Amwell aims to reach cash flow breakeven by Q4 2026. The company's market capitalization has significantly decreased from nearly $6 billion in late 2020 to approximately $87.06 million as of March 30, 2026.

Amwell experiences some seasonality in its business, typically securing a higher percentage of new client agreements and renewal agreements with existing clients in the first and fourth quarters of the year. The impact of COVID-19 on demand seasonality remains unknown, as potential future surges could influence telehealth visit demand.

Amwell, also known as American Well Corporation, is a telemedicine company that provides a SaaS-based software platform for technology-enabled healthcare, connecting patients with healthcare providers remotely through secure video. The company's major products include the Amwell Platform, Amwell Carepoint, and Amwell Converge. Amwell also offers a Behavioral Health platform and various specialty care programs. The company is strategically shifting its revenue model to focus on higher-margin subscription software contracts.

Amwell's primary operations are concentrated across the United States, where it operates in all 50 states, serving a vast network of major healthcare organizations. Amwell is actively expanding its international footprint through selective partnerships and pilot programs in the UK, Ireland, broader Europe, Israel, and Australia.

Amwell maintains a reputation as a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare. The company emphasizes its unified platform approach to help clients with consumer engagement, data fragmentation, regulatory compliance, and outcome tracking. Amwell's virtual care platform is seen by customers as a solution to improve efficiency, save costs, and grow revenue, especially amidst economic uncertainty.

American Well Corporation has 77 institutional owners and shareholders holding a total of 5,636,294 shares, including major holders like Morgan Stanley and Vanguard Group Inc. Individual investors collectively own a significant portion of the company, holding 44% of the shares. The CEO, Ido Schoenberg, owns 4.8% of the company's shares.